Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.

Browsing by Subject "Molecular Oncology Program"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Natural Products in Upper Aerodigestive Cancer: Activation of PPARγ
    (2009-04-08) Long, Jennifer E.
    Several million people across the globe are at risk for upper aerodigestive cancer. Promoting the activation of PPARγ in precancerous lesions is a novel strategy of nuclear receptor activation that shows promising chemopreventive potential. Natural products which upregulate PPARγ may therefore be an inexpensive, low toxicity approach to the prevention of upper aerodigestive cancer. This study examined several natural products which either had demonstrated chemopreventive ability or were being used in ongoing chemopreventive studies at the University of Minnesota Masonic Cancer Canter. These products, which included inositol hexaphosphate, eucalyptol, nicotinamide, nicotinic acid, trans-chalcone, 4'-methoxychalcone, and resveratrol, were tested for their ability to upregulate PPARγ DNA binding activity. Resveratrol, a product naturally found in red wine, demonstrated positive results in screening studies of PPARγ activation in aerodigestive cancer cell lines. These data show that resveratrol is an important chemopreventive target due to its ability to upregulate PPARγ. Further investigation could examine the downstream differentiation effects of resveratrol via PPARγ pathways.